President and Chief Executive Officer
My goal is to "do the right thing" for all Analyte stakeholders. Every day, I strive to understand the needs of our customers to take care of their health; identify the value proposition that is going to build our business to meet those needs; and build the team that can develop the best products and services to deliver that value. I also work hard to instill a sense of shared purpose in our team, and to support and facilitate the process of collective fact-finding, vigorous debate and decisionmaking.
Throughout my career, I have been involved with emerging businesses started by visionary founders and backed by stellar investors. My 20 years' experience include being part of the early days of enterprise software companies like Remedy, Ariba and Get2Chip; as well as the SaaS software offerings of CollabNet and consumer Internet offerings like TicketsNow. Though these businesses varied in size and scale - some going public and others being bought by public companies - they all shared a key success factor: passionate people who truly enjoyed solving customer problems in unique and innovative ways. In some cases, these innovations involved disruptions through new technologies; in other cases, the means and methods involved disruptions through business model innovations.
I am delighted to be a part of the great group of people at Analyte who constantly explore new and meaningful ways to bring quality healthcare services to our customers through business model and technology-enabled innovations.
Sue Siegel is a General Partner at Mohr, Davidow, a leading Silicon Valley venture firm. Sue leads investments in companies involved in personalized medicine, digital health, and life sciences. Prior to her VC career, Sue spent more than 20 years as a corporate leader growing biomedical companies through the commercialization of breakthrough technologies, including Bio-Rad, DuPont, Amersham (now GE), and Affymetrix. As President and Director of Affymetrix, Inc.(NASDAQ: AFFX), Sue focused on building shareholder value and grew Affymetrix into a multi-billion dollar market cap genomic company that accelerated the advent of personalized medicine. Sue serves as a board member for Pacific Biosciences, Crescendo Bioscience, Corventis, Navigenics, On-Q-ity, Newtco, Analyte Health, and RainDance Technologies.
Sue is a member of the Presidents' Circle of the National Academies and serves as an advisor to the Institute of Medicine. She is a member of Stanford’s ITI Council, DELL’s Healthcare and Life Sciences Advisory Board, and SCU’s Center for Science, Technology, and Society Board. Sue was elected as a Henry Crown Fellow of the Aspen Institute, is a member of YPO, and of Women Corporate Directors. Sue and her husband co-founded with Stanford Hospital, Checking-In™, an organization dedicated to serving our aging population. She is Board Emeritus of the Silicon Valley Tech Museum and the Gladstone.
Matthew McCall is a Partner at New World Ventures and co-founder of Draper Fisher Jurvetson Portage Venture Partners. Matthew has been responsible for managing investments in Analyte Media, Apptera, BrightTag, Cognitive Concepts (acquired by Houghton Mifflin), EverDream (acquired by Dell), Feedburner (acquired by Google), Imago Scientific (acquired by Ametek), Lefthand Networks (acquired by HP), Performics (acquired by Doubleclick/Google), Playdom (acquired by Disney), Siimpel (acquired by Tessera) and TicketsNow (acquired by Ticketmaster).
Matthew has been honored by Crain's Chicago Business on its annual "40 under 40" list of leading Chicagoans under age 40. He has also been named to the AlwaysOn Top 100 VC's in the United States, and as one of the most prominent members of Chicago's technology community. Additionally, Matthew has keynoted or been a panelist at more than 50 area conferences and events nationwide, and he’s a founder and trustee of the McCall Family Foundation, focused on improving early childhood development in Chicago's disadvantaged communities and encouraging entrepreneurship in our youth. He has served on numerous regional high technology advisory boards, and serves as an executive board member of the Illinois Venture Capital Association and on the Kellogg Alumni Council.
Before 1995, he worked in the Boston Consulting Group's Chicago office, where he managed consulting and client teams on projects in the telecommunications, healthcare and financial services industries. During and after college, Matthew worked for Bankers Trust in Merchant Banking as well as at Merrill Lynch and U.S. Trust. He holds a BA in economics and history from Williams College, an MBA with honors from Northwestern University's J.L. Kellogg Graduate School of Management and a master's degree in Manufacturing Management from Northwestern University's McCormick School of Engineering. Matthew authors a popular venture blog.
Lon Chow is a general partner with Apex Venture Partners, a Chicago-based venture capital firm. Prior to joining Apex in 1997, Lon was a partner with Mercer Management Consulting (formerly Strategic Planning Associates), where he developed and implemented growth strategies for clients in computing, media and telecommunications industries. He also held various operating management positions with Pacific Telesis.
Lon serves or previously served as director of Advanced Equities, Austin Logistics, CrowdBurst (acquired by Informative), Current Analysis, ICON Solutions (acquired by AnswerThink), KnowledgeStorm, Inc. (acquired by TechTarget), PlaceWare (acquired by Microsoft), Shoebuy.com (acquired by IAC/InterActiveCorp), Thinque Systems (acquired by MEI) and Xperex Corporation. He served as board observer of – and worked extensively with – the management teams of TRADEX Technologies (acquired by Ariba) and WorldPrints (acquired by At Home).
Lon received an MBA from the Wharton School and a BA from the University of California, Davis.
Co-founder and Vice President of Business Development
My job is to discover and analyze new product and market opportunities for our Online Clinics.
I have been part of the business of technology startups nearly my entire career, starting as a software developer in 1990 after spending two years at Anderson Consulting (now Accenture). I co-founded a software company in 1992 and an online gaming company in 1996, in both cases running the business by day and writing code by night. In 1998, I gave up being a software entrepreneur and became a full-time venture capital investor at Flatiron Partners. From 2001 to 2008, I was an independent angel investor with Feedburner, TicketsNow and several other web-based companies.
On a personal level, I was raised in the farm country of north central Indiana. I fondly remember my first job detasseling corn (maybe not so fondly, for those of you who have ever done it!). I received an engineering degree from Purdue University, an MBA from Northwestern and I'm an alumni of the Kauffman Fellows Program. For anyone interested in learning more, visit my blog.
STDTestExpress.com, winner of the 2010 Healthcare Standard of Excellence WebAward, is focused on the self-pay market for testing, treatment and counseling for sexually transmitted diseases and infections.
We're growing and always looking for amazing and motivated people to help us deliver outstanding Online Clinics. Please send us your resume with a cover letter that explains why you'd be a great addition to our team: jobs@analytemedia.com.